Dr Lal Path Labs delivered a beat on margins at 28.2 per cent. However, revenue was in-line while EBITDA/PAT delivered a slight beat by 4/5 per cent respectively. Overall revenue increased 11 per cent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback